Oil-Dri Corp of America
For the period ended Jul 31, 2025. Filed Oct 9, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Oct 9, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Financial Statements and Supplementary Data
| July 31, | ||
|---|---|---|
| 2025 | 2024 | |
| ASSETS · (in thousands) | ||
| Current Assets | ||
| Cash and cash equivalents | $50,458 | $23,481 |
| Accounts receivable, less allowance of $1,493 and $934 in 2025 and 2024, respectively | 69,370 | 62,171 |
| Inventories, net | 51,594 | 54,236 |
| Prepaid expenses and other assets | 5,961 | 7,270 |
| Total Current Assets | 177,383 | 147,158 |
| Property, Plant and Equipment | ||
| Land | 13,549 | 13,550 |
| Buildings and leasehold improvements | 43,529 | 41,648 |
| Machinery and equipment | 205,675 | 192,788 |
| Office furniture and equipment | 22,521 | 22,530 |
| Vehicles | 25,902 | 24,617 |
| Construction in progress | 25,149 | 20,974 |
| Mining assets | 10,893 | 9,966 |
| Capital parts | 8,861 | 7,488 |
| Less accumulated depreciation and amortization | (206,375) | (195,765) |
| Total Property, Plant and Equipment, Net | 149,704 | 137,796 |
| Other Assets | ||
| Goodwill | 16,017 | 15,443 |
| Trademarks, trade names and patents, net of accumulated amortization of $693 and $625 in 2025 and 2024, respectively | 6,603 | 6,662 |
| Customer list, net of accumulated amortization of $9,278 and $8,149 in 2025 and 2024, respectively | 18,907 | 20,036 |
| Deferred income taxes | 1,291 | 1,537 |
| Operating lease right-of-use assets | 14,219 | 18,667 |
| Other | 7,553 | 7,306 |
| Total Other Assets | 64,590 | 69,651 |
| Total Assets | $391,677 | $354,605 |
(continued)
| July 31, | ||
|---|---|---|
| 2025 | 2024 | |
| LIABILITIES AND STOCKHOLDERS’ EQUITY · (in thousands) | ||
| Current Liabilities | ||
| Current maturities of notes payable | $1,000 | $1,000 |
| Accounts payable | 16,808 | 15,009 |
| Dividends payable | 2,444 | 2,096 |
| Operating lease liabilities | 4,071 | 4,556 |
| Accrued expenses | 44,864 | 44,016 |
| Total Current Liabilities | 69,187 | 66,677 |
| Noncurrent Liabilities | ||
| Long-term debt, net of unamortized debt issuance costs of $183 and $226 in 2025 and 2024, respectively | 38,817 | 49,774 |
| Deferred compensation | 5,777 | 5,667 |
| Long-term operating lease liabilities | 11,296 | 15,391 |
| Other | 7,540 | 6,508 |
| Total Noncurrent Liabilities | 63,430 | 77,340 |
| Total Liabilities | 132,617 | 144,017 |
| Commitments and Contingencies (See Note 11) | ||
| Stockholders’ Equity | ||
| Common Stock, par value $.10 per share, issued 15,276,261 shares in 2025 and 15,172,186 shares in 2024 | 1,528 | 1,517 |
| Class B Stock, convertible, par value $.10 per share, issued 4,650,484 shares in 2025 and 4,652,984 shares in 2024 | 465 | 465 |
| Additional paid-in capital | 66,138 | 60,031 |
| Retained earnings | 277,500 | 232,247 |
| Accumulated other comprehensive income | 969 | 769 |
| Less treasury stock, at cost (4,902,881 Common and 380,628 Class B shares in 2025 and 4,867,880 Common and 362,649 Class B shares in 2024) | (87,540) | (84,441) |
| Total Stockholders’ Equity | 259,060 | 210,588 |
| Total Liabilities and Stockholders’ Equity | $391,677 | $354,605 |
| Year Ended July 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| (in thousands, except for per share data) | |||
| Net Sales | $485,572 | $437,587 | $413,021 |
| Cost of Goods Sold | (342,489) | (312,493) | (309,794) |
| Gross Profit | 143,083 | 125,094 | 103,227 |
| Selling, General and Administrative Expenses | (74,863) | (73,449) | (62,187) |
| Income from Operations | 68,220 | 51,645 | 41,040 |
| Other (Expense) Income | |||
| Interest income | 698 | 873 | 465 |
| Interest expense | (2,434) | (1,804) | (1,464) |
| Loss on pension termination | — | — | (4,652) |
| Foreign exchange (loss) gain | (522) | (628) | 105 |
| Other, net | 249 | (435) | (816) |
| Total Other Expense, Net | (2,009) | (1,994) | (6,362) |
| Income Before Income Taxes | 66,211 | 49,651 | 34,678 |
| Income Tax Expense | (12,215) | (10,225) | (5,195) |
| Net Income | $53,996 | $39,426 | $29,483 |
| Net Loss Attributable to Noncontrolling Interest | — | — | (68) |
| Net Income Attributable to Oil-Dri | $53,996 | $39,426 | $29,551 |
| Net Income Per Share | |||
| Basic Common Stock | $3.99 | $2.92 | $2.23 |
| Basic Class B Stock | $3.00 | $2.20 | $1.67 |
| Diluted Common Stock | $3.70 | $2.72 | $2.07 |
| Diluted Class B Stock | $3.00 | $2.20 | $1.67 |
| Average Shares Outstanding | |||
| Basic Common Stock | 9,889 | 9,771 | 9,651 |
| Basic Class B Stock | 3,994 | 3,952 | 3,917 |
| Diluted Common Stock | 13,883 | 13,723 | 13,568 |
| Diluted Class B Stock | 3,994 | 3,952 | 3,917 |
| Dividends Declared Per Share | |||
| Common Stock | 0.645 | 0.590 | 0.565 |
| Class B Stock | 0.485 | 0.444 | 0.424 |
| Year Ended July 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| (in thousands) | |||
| Net Income Attributable to Oil-Dri | $53,996 | $39,426 | $29,551 |
| Other Comprehensive Income (Loss): | |||
| Pension and postretirement benefits, net of tax | 129 | 64 | 3,254 |
| Cumulative translation adjustment | 71 | (43) | (323) |
| Other Comprehensive Income | 200 | 21 | 2,931 |
| Comprehensive Income | $54,196 | $39,447 | $32,482 |
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
| Number of Shares · (in thousands) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Common& Class BStock | TreasuryStock | Common& Class BStock | AdditionalPaid-InCapital | RetainedEarnings | TreasuryStock | AccumulatedOtherComprehensiveIncome (Loss) | Non-Controlling Interest | TotalStockholders’Equity | |
| Balance, July 31, 2022 | 19,547,265 | (5,127,274) | $1,954 | $51,621 | $178,754 | $(79,428) | $(2,183) | $(369) | $150,349 |
| Net Income (Loss) | — | — | $— | $— | $29,551 | $— | $— | $(68) | $29,483 |
| Other Comprehensive Income | — | — | $— | $— | $— | $— | $2,931 | $— | $2,931 |
| Dividends Declared | — | — | $— | $— | $(7,509) | $— | $— | $— | $(7,509) |
| Purchases of Treasury Stock | — | (25,055) | $— | $— | $— | $(1,078) | $— | $— | $(1,078) |
| Net Issuance of Stock Under Long-Term Incentive Plan | 63,455 | (23,996) | $7 | $695 | $— | $(701) | $— | $— | $1 |
| Amortization of Restricted Stock | — | — | $— | $3,147 | $— | $— | $— | $— | $3,147 |
| Contributions from noncontrolling interests | — | — | $— | $(685) | $— | $— | $— | $437 | $(248) |
| Balance, July 31, 2023 | 19,610,720 | (5,176,325) | $1,961 | $54,778 | $200,796 | $(81,207) | $748 | $— | $177,076 |
| Net income (loss) | — | — | — | — | 39,426 | — | — | — | 39,426 |
| Other comprehensive income | — | — | — | — | — | — | 21 | — | 21 |
| Dividends declared | — | — | — | — | (7,975) | — | — | — | (7,975) |
| Purchases of treasury stock | — | (42,554) | — | — | — | (2,778) | — | — | (2,778) |
| Net issuance of stock under long-term incentive plans | 214,450 | (11,650) | 21 | 434 | — | (456) | — | — | (1) |
| Amortization of restricted stock | — | — | — | 4,819 | — | — | — | — | 4,819 |
| Balance, July 31, 2024 | 19,825,170 | (5,230,529) | $1,982 | $60,031 | $232,247 | $(84,441) | $769 | $— | $210,588 |
| Net income | — | — | — | — | 53,996 | — | — | — | 53,996 |
| Other comprehensive income | — | — | — | — | — | — | 200 | — | 200 |
| Dividends declared | — | — | — | — | (8,743) | — | — | — | (8,743) |
| Purchases of treasury stock | — | (36,958) | — | — | — | (2,349) | — | — | (2,349) |
| Net issuance of stock under long-term incentive plans | 101,575 | (16,022) | 11 | 739 | — | (750) | — | — | — |
| Amortization of restricted stock | — | — | — | 5,368 | — | — | — | — | 5,368 |
| Balance, July 31, 2025 | 19,926,745 | (5,283,509) | $1,993 | $66,138 | $277,500 | $(87,540) | $969 | $— | $259,060 |
| Year-Ended July 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| (in thousands) | |||
| Cash Flows from Operating Activities | |||
| Net income | $53,996 | $39,426 | $29,483 |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Depreciation and amortization | 22,042 | 19,281 | 15,528 |
| Non-cash stock compensation expense | 5,368 | 4,819 | 3,147 |
| Loss on pension termination | — | — | 4,652 |
| Deferred income tax expense (provision) | 240 | 1,697 | (4,431) |
| Net increase (decrease) to provision for bad debts and cash discounts | 559 | (153) | 284 |
| Loss on impairment of patent applications | 49 | — | 61 |
| Accretion for asset retirement obligation | 190 | 211 | 161 |
| (Gain) loss on sale of fixed assets | (31) | 314 | 1,044 |
| (Increase) decrease in: | |||
| Accounts receivable | (7,789) | 1,453 | (7,899) |
| Inventories | 2,336 | (4,682) | (2,204) |
| Prepaid expenses | 191 | (2,431) | 1,082 |
| Deferred income taxes | 31 | (115) | 510 |
| Other assets | 4,095 | 3,404 | 59 |
| Increase (decrease) in: | |||
| Accounts payable | 926 | (2,794) | 3,241 |
| Accrued expenses | 2,384 | 2,449 | 6,455 |
| Deferred compensation | 110 | 1,155 | (47) |
| Other liabilities | (4,514) | (3,721) | (1,362) |
| Total Adjustments | 26,187 | 20,887 | 20,281 |
| Net Cash Provided by Operating Activities | 80,183 | 60,313 | 49,764 |
| Cash Flows from Investing Activities | |||
| Capital expenditures | (32,562) | (32,000) | (24,368) |
| Proceeds from sale of property, plant and equipment | 151 | 182 | 70 |
| Acquisition of business | (115) | (44,298) | — |
| Acquisition of equity in Agromex | — | — | (269) |
| Net Cash Used in Investing Activities | (32,526) | (76,116) | (24,567) |
| Cash Flows from Financing Activities | |||
| Proceeds from issuance of notes payable | — | 20,000 | $— |
| Principal payments on notes payable | (11,000) | (1,000) | (1,000) |
| Payment of debt issuance costs | — | (90) | (7) |
| Dividends paid | (8,395) | (7,806) | (7,433) |
| Purchase of treasury stock | (2,349) | (2,778) | (1,078) |
| Net Cash (Used in) Provided by Financing Activities | (21,744) | 8,326 | (9,518) |
| Effect of exchange rate changes on cash and cash equivalents | 64 | 204 | (223) |
| Net Increase (Decrease) in Cash and Cash Equivalents | 25,977 | (7,273) | 15,456 |
| Cash, Cash Equivalents and Restricted Cash, Beginning of Year | 24,481 | 31,754 | 16,298 |
| Cash, Cash Equivalents and Restricted Cash, End of Year | $50,458 | $24,481 | $31,754 |
| Year-Ended July 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| (in thousands) | |||
| Supplemental disclosure: | |||
| Restricted Cash: | |||
| Beginning balance | $1,000 | $— | — |
| (Decrease) increase to restricted cash | $(885) | $1,000 | — |
| Final settlement of acquisition of Ultra Pet | $(115) | $— | — |
| Ending balance | $— | $1,000 | — |
| Other cash flows: | |||
| Interest payments, net of amounts capitalized | $1,697 | $1,089 | $1,135 |
| Income tax payments | $12,598 | $10,006 | $7,367 |
| Noncash investing and financing activities: | |||
| Change in capital expenditures in accounts payable | $876 | 458 | 326 |
| Change in capital expenditures in accrued expenses | $(1,553) | $3,380 | $357 |
| Cash dividends declared and accrued, but not paid | $2,444 | $2,096 | $1,927 |
| Increase in reclamation asset and liability | $926 | $79 | $522 |
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1 –SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
NATURE OF OPERATIONS
We are a leader in developing, manufacturing and/or marketing sorbent products. Our sorbent products are principally produced from clay minerals. Our absorbent clay products include cat litter, industrial floor absorbents, agricultural chemical carriers and animal feed additives. Our adsorbent products include bleaching clays, which are used for filtration of edible oils, pre-treatment of renewable diesel, and for purification of petroleum-based oils. We also sell synthetic sorbents, which are used for industrial cleanup and cat litter.
PRINCIPLES OF CONSOLIDATION
The Consolidated Financial Statements include the accounts of Oil-Dri Corporation of America and its subsidiaries. All significant intercompany balances and transactions have been eliminated from the Consolidated Financial Statements.
RECLASSIFICATION
Certain amounts in the prior period financial statements have been reclassified to conform to the presentation of the current period financial statements. These immaterial reclassifications had no effect on the previously reported net income or net cash flows.
MANAGEMENT'S USE OF ESTIMATES
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period as well as the related disclosures. Estimates and assumptions about future events cannot be made with certainty. All of our estimates and assumptions are revised periodically. Actual results could differ from these estimates.
CASH, CASH EQUIVALENTS ANDR ESTRICTEDCASH
Cash equivalents are highly liquid investments with maturities ofthree months or less.
The following table provides a reconciliation of cash, cash equivalents and restricted cash as of July 31, 2025, and 2024 reported within the Consolidated Balance Sheets that sum to the total of the same such amounts shown in the Consolidated Statement of Cash Flows (in thousands):
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Cash and cash equivalents | $50,458 | $23,481 | $31,754 |
| Restricted cash included in prepaid expenses and other assets | — | 1,000 | — |
| Cash, cash equivalents, and restricted cash | $50,458 | $24,481 | $31,754 |
TRADE RECEIVABLES
We recognize trade receivables when control of finished products is transferred to our customers. We record an allowance for credit losses based on our expectations and a periodic review of our accounts receivable, including a review of the overall aging of accounts, consideration of customer credit risk and analysis of facts and circumstances about specific accounts. A customer account is determined to be uncollectible when it is probable that a loss will be incurred after we have completed our internal collection procedures, including termination of shipments, direct customer contact and formal demand of payment. We retain outside collection agencies to facilitate our collection efforts. Past due status is determined based on contractual terms and customer payment history. We also include an allowance for expected cash discounts to be taken by our customers.
INVENTORIES
The composition of inventories was as follows as of July 31 (in thousands):
| 2025 | 2024 | |
|---|---|---|
| Finished goods | $29,401 | $31,772 |
| Packaging | 8,114 | 8,995 |
| Spare parts | 6,822 | $7,059 |
| Other | 7,257 | 6,410 |
| Inventories, net | $51,594 | $54,236 |
Inventories are valued at the lower of cost (first-in, first-out) or net realizable value. Inventory costs include the cost of raw materials, packaging supplies, labor and other overhead costs. We performed a detailed review of our inventory items to determine if an obsolescence reserve adjustment was necessary. The review surveyed all of our operating facilities and sales groups to ensure that both historical issues and new market trends were considered. The obsolescence reserve not only considers specific items but also takes into consideration the overall value of the inventory as of the balance sheet date. We recorded inventory reserves of $3.7 million as of July 31, 2025, and $3.8 million as of July 31, 2024. The other category of inventories includes a variety of items including clay, additives, fragrances and other supplies. Spare parts in inventory are recorded net of a valuation reserve based on aging.
TRANSLATION OF FOREIGN CURRENCIES
Assets and liabilities of foreign subsidiaries, where the local currency is the functional currency, are translated to U.S. dollars at the exchange rates in effect at period end. Income statement items are translated at the average exchange rate on a monthly basis. Resulting translation adjustments are recorded as a separate component of stockholders’ equity.
INTANGIBLES AND GOODWILL
Our intangible assets are mainly comprised of customer lists, patents, trademarks, trade names and goodwill. We amortize customer lists and patents on a straight-line basis over periods ranging from 18 to 20 years. During fiscal year 2024 we recorded additions of intangible assets of $37.4 million related to the acquisition of Ultra Pet, the components of which were customer list of $20.4 million amortized over a useful life of 18 years, $5.2 million of trade name and $11.8 million of goodwill. During fiscal year 2025, certain measurement period adjustments were made to goodwill resulting in a $0.6 million increase to goodwill.
Intangible amortization was $1.2 million, $0.5 million, and $0.3 million in fiscal years 2025, 2024, and 2023 respectively.
Our estimated intangible amortization expense for the next five fiscal years is as follows (in thousands):
| 2026 | $1,217 |
| 2027 | $1,217 |
| 2028 | $1,217 |
| 2029 | $1,217 |
| 2030 | $1,217 |
The remaining weighted average amortization period of our intangibles subject to amortization is as follows (in years):
| Weighted Average Amortization Period | |
|---|---|
| Patents | 8.8 |
| Customer list | 16.8 |
| Total intangible assets subject to amortization | 16.6 |
Trademarks and trade names acquired through acquisitions were determined to have indefinite lives. We had $5.6 million in indefinite life trademarks and trade names as of both July 31, 2025, and 2024.
Goodwill by operating segment was as follows as of July 31 (in thousands):
| 2025 | 2024 | |
|---|---|---|
| Business to Business | 3,618 | 3,618 |
| Retail and Wholesale | $12,399 | 11,825 |
| Total | $16,017 | $15,443 |
We review indefinite-lived intangibles and goodwill to assess for impairment on the first day of our fiscal fourth quarter, or more frequently if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value. We also perform a review for indicators of impairment each quarter to assess whether an interim impairment review is required for any reporting unit. Our review entails a qualitative analysis of triggering events and, if identified, a further analysis is performed based on cash flow considerations and other approaches that require significant judgment with respect to volume, revenue, expenses and allocations. Impairment occurs when the carrying value exceeds the fair value. We performed our impairment assessment and identified no triggering events that indicate the need for impairment of indefinite intangible assets or goodwill in either 2025 or 2024.
PROPERTY, PLANT AND EQUIPMENT
Property, plant and equipment are depreciated using the straight-line method over their estimated useful lives. The useful lives for most of our depreciable assets range from 2 to 25 years, with some buildings ranging up to 30 years. Depreciation expense was $20.8 million, $18.8 million, and $15.3 million in fiscal years 2025, 2024, and 2023 respectively. Major improvements and betterments are capitalized, while maintenance and repairs that do not extend the useful life or increase functionality of the applicable assets are expensed as incurred. Interest expense may also be capitalized for assets that require a period of time to get them ready for their intended use. There wasno capitalized interest in fiscal years 2025 and 2024.
Property, plant and equipment are carried at cost on the Consolidated Balance Sheets and are reviewed for possible impairment when circumstances indicate that an asset may be impaired. We take into consideration idle and underutilized equipment and review business plans for possible impairment. When impairment is indicated, an impairment charge is recorded for the difference between the carrying value of the asset and its fair market value. In fiscal year 2025, we recognizedno impairment for fixed assets no longer in use. We recognized impairment for fixed assets of $0.1 million in fiscal year 2024 and $0.9 million in fiscal year 2023. Impairment is included in cost of goods sold on the Consolidated Statement of Operations.
LAND ANDM ININGA SSETS
Our mining assets include mining properties, mineral rights and reclamation assets. We surface mine sorbent minerals on property that we either own or lease. A significant part of our mining cost is incurred during the process of removing the overburden from the mine site, thus exposing the sorbent material used in a majority of our production processes. Pre-production overburden removal costs associated with opening a new mine during the development phase are deferred. There wasno capitalized pre-production costs incurred in either fiscal year 2025 or 2024. Capitalized development costs are amortized when the sorbent material is removed from the mine and used to produce product for sale. At the end of fiscal year 2025, the amount of development costs that are being amortized is $3.5 million. Stripping costs incurred during production are treated as a variable inventory production cost and are included in cost of goods sold. Stripping costs included in cost of goods sold were approximately $4.7 million, $5.4 million, and $4.0 million for fiscal years 2025, 2024, and 2023, respectively.
Additionally, it is our policy to capitalize the purchase cost of land and mineral rights, including associated legal, survey, and real estate fees. The costs of obtaining mineral rights, including legal fees and drilling expenses, are also capitalized. As of both fiscal years ending July 31, 2025, and July 31, 2024, we had $13.5 million of land and $2.2 million of gross mineral rights. Any prepaid royalties that may be offset against future royalties due upon extraction of the mineral are also capitalized. Prepaid royalties included in current prepaid expenses and in non-current other assets on the Consolidated Balance Sheets were approximately $2.4 million as of July 31, 2025, and $2.3 million as of July 31, 2024.
RECLAMATION
We perform ongoing reclamation activities during the normal course of our overburden removal. As overburden is removed from a mine site, it is hauled to previously mined sites and is used to refill the older sites. This process allows us to continuously reclaim older mine sites and dispose of overburden simultaneously, therefore minimizing the costs associated with the reclamation process.
On an annual basis we evaluate our potential reclamation liability in accordance with ASC 410, Asset Retirement and Environmental Obligations. Reclamation assets are depreciated over the estimated useful lives of the various mines. Reclamation liabilities are increased based on a yearly accretion charge over the estimated useful lives of the mines.
We recorded an estimated net reclamation asset of $3.1 million as of July 31, 2025, and $2.2 million as of July 31, 2024, and a corresponding estimated reclamation liability of $5.9 million as of July 31, 2025, and $4.8 million as of July 31, 2024. These values represent the discounted present value of the estimated future mining reclamation and landfill closure costs at the production plants. Additional mining activity, disturbance of land, and higher costs account for a majority of the increase in the reclamation liability.
TRADE PROMOTIONS
We routinely commit to one-time or ongoing trade promotion programs, primarily in our Retail and Wholesale Products Group. All such costs are netted against sales. We have accrued liabilities at the end of each period for the estimated expenses incurred but not yet paid for these programs. Promotional reserves are provided for sales incentives made directly to consumers, such as coupons, and sales incentives made to customers, including slotting, discounts based on sales volume, cooperative marketing programs and other arrangements. We rely on our historical experience of trade spending patterns and that of the industry, current trends and forecast data to record estimates of our trade spending liabilities.
FAIR VALUE OF FINANCIAL INSTRUMENTS
Non-derivative financial instruments included in the Consolidated Balance Sheets are cash and cash equivalents, short-term investments, credit facilities, and notes payable. These instruments, except for debt, were carried at amounts approximating fair value as of July 31, 2025, and 2024. See Note 5 of the Notes to the Consolidated Financial Statements for additional information regarding the fair value of our financial instruments, including notes payable.
REVENUE RECOGNITION
We recognize revenue when performance obligations under the terms of the contracts with customers are satisfied. Our performance obligation generally consists of the promise to sell finished products to wholesalers, distributors, retailers or consumers and our obligations have an original duration of one year or less. Control of the finished products are transferred upon shipment to, or receipt at, customers' locations, as determined by the specific terms of the contract. We have completed our performance obligation when control is transferred, and we recognize revenue accordingly. Taxes collected from customers and remitted to governmental authorities are excluded from net sales. Sales returns are not material nor are warranties or any related obligations.
We have an unconditional right to consideration under the payment terms specified in the contract upon completion of the performance obligation. We may require certain customers to provide payment in advance of product shipment. We recorded a liability of $0.3 million as of July 31, 2025, for these advance payments. There is $0.2 million liability for advance payments as of July 31, 2024. This liability is reported in Other Accrued Expenses on the Consolidated Balance Sheets. There is $0.2 million revenue recognized during fiscal year 2025 that was included in the liability for advance payments at the beginning of the year.
COST OFGOODSSOLD
Cost of goods sold consists of all manufacturing costs, including depreciation and amortization related to assets used in the manufacturing and distribution process, inbound and outbound freight, inspection costs, purchasing costs associated with materials and packaging used in the production process and warehouse and distribution costs. Natural gas forward contracts are accounted for as normal purchases.
SHIPPING AND HANDLING COSTS
Shipping and handling costs are included in cost of goods sold and were approximately $64.9 million, $59.2 million, and $57.4 million for fiscal years 2025, 2024, and 2023, respectively.
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES
Selling, general and administrative expenses include salaries, wages and benefits associated with staff outside the manufacturing and distribution functions, all marketing related costs, any miscellaneous trade spending expenses not required to be included in net sales, research and development costs, depreciation and amortization related to assets outside the manufacturing and distribution process and all other non-manufacturing and non-distribution expenses.
ADVERTISING
Advertising costs for the development of printed materials, television commercials, web-based digital banners, web-based social media and sales videos are deferred and expensed upon the first use of the materials. Costs paid for communicating advertising over a period of time, such as television air time, radio commercials and print media advertising space, are deferred and expensed on a pro-rata basis. All other advertising costs, including participation in industry conventions and shows and market research, are expensed when incurred. All advertising costs are part of selling, general and administrative expenses. Advertising expenses were approximately $7.6 million, $9.0 million, $7.3 million in fiscal years 2025, 2024, and 2023, respectively.
RESEARCH AND DEVELOPMENT
Research and development costs of approximately $2.4 million, $2.1 million, and $1.2 million were charged to expense as incurred for fiscal years 2025, 2024, and 2023, respectively, and are recorded in selling, general and administrative expenses.
STOCK-BASED COMPENSATION
We account for stock options and restricted stock issued under our long-term incentive plans in accordance with ASC 718, Compensation – Stock Compensation. The fair value of stock-based compensation is determined at the grant date. The related compensation expense is recognized over the appropriate vesting period. Forfeitures are recognized as they occur. See Note 8 of the Notes to the Consolidated Financial Statements for additional information.
INCOMET AXES
Deferred income tax assets and liabilities are recorded for the impact of temporary differences between the tax basis of assets and liabilities and the amounts recognized for financial reporting purposes. Deferred tax assets are reviewed, and a valuation allowance is established if management believes that it is more likely than not that some portion of our deferred tax assets will not be realized. Changes in valuation allowances from period to period are included in the tax provision in the period of change.
In addition to existing valuation allowances, we provide for uncertain tax positions, if necessary, when such tax positions do not meet the recognition thresholds or measurement standards prescribed by ASC 740, Income Taxes. Amounts for uncertain tax positions are adjusted when new information becomes available or when positions are effectively settled. We recognize interest and penalties accrued related to uncertain tax positions in income tax expense.
U.S. income tax expense and foreign withholding taxes are provided on remittances of foreign earnings and on unremitted foreign earnings that are not indefinitely reinvested. Where unremitted foreign earnings are indefinitely reinvested, no provision for federal or state tax expense is recorded. When circumstances change and we determine that some or all of the undistributed earnings will be remitted in the foreseeable future, a corresponding expense is accrued in the current period. See Note 6 of the Notes to the Consolidated Financial Statements for additional information about income taxes.
STOCKS PLIT
On October 9, 2024, we announced that our Board approved atwo-for-one stock split in the form of a stock dividend. Stockholders of record as of the close of business on December 20, 2024 received a distribution ofone additional share of Common Stock, for each share of Common Stock held by such stockholder andone additional share of Class B Stock for each share of Class B Stock held by such stockholder as of the record date. The additional shares were distributed on January 3, 2025, and our Common Stock began trading on a post-split basis on January 6, 2025.
The stock split did not affect the par value of the Common Stock or Class B Stock, however, in order to implement the stock split, we amended our Certificate of Incorporation on December 11, 2024 to increase the number of authorized shares of Common Stock from 15 million to 30 million. Proportionate adjustments were made to the number of shares that remain available for issuance pursuant to the 2006 Plan, as well as to the outstanding awards under the 2006 Plan.
Unless noted, all Common Stock and Class B Stock share and per share amounts contained in the Condensed Consolidated Financial Statements have been retroactively adjusted, where applicable, to reflect the stock split. The impact on the Condensed Consolidated Balance Sheet and Condensed Consolidated Statements of Stockholders' Equity herein was an increase of $0.8 million to Common Stock and Class B Stock, with an offsetting decrease in Additional Paid-In-Capital, which has been retroactively adjusted as if the stock split had occurred at the beginning of the earliest period presented. The change in treasury shares reflects the stock split on shares held by wholly owned subsidiaries which are presented as treasury shares on a consolidated basis.
EARNINGSPERS HARE
We utilize the two-class method to report our earnings per share ("EPS"). The two-class method is an earnings allocation formula that determines EPS for each class of common stock according to dividends declared and participation rights in undistributed earnings. Common Stock is entitled to cash dividends equal to at least 133.33% on a per share basis of the cash dividend paid on Class B Stock. In computing EPS, the Company has allocated dividends declared to shares of Common Stock and Class B Stock based on amounts declared for each class of stock and 33.33% more of the undistributed earnings have been allocated to shares of Common Stock than to shares of Class B Stock on a per share basis. Common Stock is entitled toone vote per share and Class B Stock is entitled toten votes per share. Common Stock have no conversion rights. Class B Stock is convertible by the holders thereof on a share-by-share basis into Common Stock at any time and is subject to mandatory conversion under certain circumstances. Basic EPS is computed by dividing net earnings, reduced for any distributed and undistributed earnings allocated to unvested restricted shares, by the weighted-average number of shares outstanding during the period for each class of common stock. Diluted EPS for Common Stock is derived utilizing the most dilutive result of the if-converted, treasury stock and two-class methods. In our case, the if-converted method is more dilutive than the two-class method and because our unvested restricted stock participates in dividends and is therefore anti-dilutive the treasury stock method does not apply. For Class B Stock, diluted EPS is derived utilizing the two-class method since, as with our Common Stock, our unvested restricted stock participates in dividends and is therefore anti-dilutive, making the treasury stock method inapplicable. The reverse treasury stock method is also inapplicable to both classes as we have no obligation to repurchase our Common Stock or Class B Stock. In both the if-converted and two-class methods, diluted EPS is computed by dividing net earnings by the weighted-average number of shares and potential shares outstanding during the period, taking into consideration different potential shares outstanding based on the method used. Dilution for Common Stock takes into consideration the effect of both unvested restricted shares and convertible shares of Class B Stock, unless such shares are anti-dilutive, in which case they are not considered. Dilution for Class B Stock takes into consideration the effect of unvested restricted shares, unless such shares are anti-dilutive, in which case they are not considered.
Below is a reconciliation of the calculation of basic and diluted EPS.
| For the year ended July 31, 2025 | |||||
|---|---|---|---|---|---|
| (in thousands, except for per share data) | |||||
| Total · Common · Class B | |||||
| Net income | $53,996 | $41,173 | $12,823 | ||
| Distributed and undistributed earnings on restricted shares | (2,580) | (1,732) | (848) | ||
| Income available to stockholders | $51,416 | $39,441 | $11,975 | ||
| Net Income (Numerator) | $39,441 | $11,975 | |||
| Weighted Average Shares Outstanding (Denominator) | 9,889 | 3,994 | |||
| Basic EPS | $3.99 | $3.00 | |||
| Effect of dilution - Net Income (1) | $11,975 | $— | |||
| Net income assuming dilution (Numerator) | $51,416 | $11,975 | |||
| Effect of dilution - Shares (1) | 3,994 | $— | |||
| Shares assuming dilution (Denominator) | 13,883 | $3,994 | |||
| Diluted EPS | $3.70 | $3.00 | |||
| (1) The impact of 275,327 shares of unvested Common Stock and 139,484 shares of unvested Class B Stock, restricted stock was anti-dilutive therefore not included in the calculation of diluted EPS for the year ended July 31, 2025 | |||||
| For the year ended July 31, 2024 | |||||
|---|---|---|---|---|---|
| (in thousands, except for per share data) | |||||
| Total · Common · Class B | |||||
| Net income | $39,426 | $29,981 | $9,445 | ||
| Distributed and undistributed earnings on restricted shares | (2,165) | (1,410) | (755) | ||
| Income available to stockholders | $37,261 | $28,571 | $8,690 | ||
| Net Income (Numerator) | $28,571 | $8,690 | |||
| Weighted Average Shares Outstanding (Denominator) | 9,771 | 3,952 | |||
| Basic EPS | $2.92 | $2.20 | |||
| Effect of dilution - Net Income (2) | $8,690 | $— | |||
| Net income assuming dilution (Numerator) | $37,261 | $8,690 | |||
| Effect of dilution - Shares (2) | 3,952 | $— | |||
| Shares assuming dilution (Denominator) | 13,723 | $3,952 | |||
| Diluted EPS | $2.72 | $2.20 | |||
| (2) The impact of 317,722 shares of unvested Common Stock and 108,740 shares of unvested Class B Stock, restricted stock was anti-dilutive therefore not included in the calculation of diluted EPS for the year ended July 31, 2024. | |||||
| For the year ended July 31, 2023 | |||||
|---|---|---|---|---|---|
| (in thousands, except for per share data) | |||||
| Total · Common · Class B | |||||
| Net income | $29,551 | $22,712 | $6,839 | ||
| Distributed and undistributed earnings on restricted shares | (1,518) | (1,232) | (286) | ||
| Income available to stockholders | $28,033 | $21,480 | $6,553 | ||
| Net Income (Numerator) | $21,480 | $6,553 | |||
| Weighted Average Shares Outstanding (Denominator) | 9,651 | 3,917 | |||
| Basic EPS | $2.23 | $1.67 | |||
| Effect of dilution - Net Income (2) | $6,553 | $— | |||
| Net income assuming dilution (Numerator) | $28,033 | $6,553 | |||
| Effect of dilution - Shares (2) | 3,917 | $— | |||
| Shares assuming dilution (Denominator) | 13,568 | $3,917 | |||
| Diluted EPS | $2.07 | $1.67 | |||
| (2) The impact of 314,064 shares of unvested Common Stock and 71,390 shares of unvested Class B Stock, restricted stock was anti-dilutive therefore not included in the calculation of diluted EPS for the year ended July 31, 2023 | |||||
NEW ACCOUNTING PRONOUNCEMENTS
Recently Adopted Accounting Standards
In November 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures" ("ASU 2023-07"). These amendments primarily require enhanced disclosures about significant segment expenses regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss. In addition, ASU No. 2023-07 also requires all annual disclosures currently required by Topic 280 to be included in interim periods. These amendments are to be applied retrospectively for all periods presented in the financial statements and are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. Refer to Note 3 - Operating Segments of this Form 10-K for the enhanced disclosures added as a result of the adoption of ASU 2023-07.
Recently Issued Accounting Standards Not Yet Adopted
In December 2023, the FASB issued ASU No. 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures" ("ASU 2023-09"). These amendments primarily require enhanced disclosures and disaggregation of income tax information by jurisdiction in the annual income tax reconciliation and quantitative disclosures regarding income taxes paid. These amendments are to be applied prospectively, with the option to apply the standard retrospectively, for annual periods beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating the impact that the adoption of this guidance will have on our disclosures.
In November 2024, the FASB issued ASU No. 2024-03, "Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses" ("ASU 2024-03"). The pronouncement expands the disclosure requirements for expenses, specifically by providing more detailed information about the types of expenses in commonly presented expense captions. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. We are currently evaluating the impact that ASU 2024-03 will have on the Company's consolidated financial statement disclosures.
NOTE 2 – ACQUISITION
Ultra Pet acquisition
On May 1, 2024, pursuant to a Stock Purchase Agreement (the “Purchase Agreement”), dated April 16, 2024, we acquired all of the issued and outstanding shares of capital stock of Ultra Pet, in order to enter into the crystal cat litter segment. Ultra Pet became a wholly owned and consolidated subsidiary of Oil-Dri within the Retail and Wholesale Products Group operating segment, upon the closing of the acquisition on May 1, 2024.
The purchase was financed through cash on hand, a$10 million advance under the Credit Agreement, and the issuance of$10 million in aggregate principal amount of 6.47% Series D Senior Notes due April 30, 2033, pursuant to the shelf facility provisions of the Note Agreement. Debt issuance costs of$0.1 million were deferred and are being amortized over the life of the note. During fiscal year 2025, the 10 million advance under the Credit Agreement was repaid in full. Refer to Note 4 of the Consolidated Financial Statements for additional details regarding the debt used in funding the acquisition.
As of July 31, 2025, the Company has completed the assessment to assign fair values to all tangible and intangible assets acquired and liabilities assumed. During fiscal year 2025, goodwill increased $0.6 million as a result of measurement period adjustments to inventory, accounts receivable, deferred tax and other assets and to account for the final purchase price adjustments. The following table summarizes the final consideration paid and fair value of the assets acquired, and liabilities assumed at the acquisition date.
| Consideration · (in thousands) | |
|---|---|
| Cash, net of cash acquired and restricted cash | $44,413 |
| Identifiable assets acquired and liabilities assumed | |
| Accounts receivable | 4,246 |
| Inventories | 6,751 |
| Prepaid expenses and other assets | 877 |
| Property, plant and equipment | 270 |
| Trade name | 5,200 |
| Customer list | 20,400 |
| Operating lease right-of-use assets | 1,463 |
| Trade and other liabilities | (1,663) |
| Operating lease right-of-use liabilities | (1,472) |
| Deferred tax liabilities | (4,058) |
| Total identifiable net assets | 32,014 |
| Goodwill | 12,399 |
| Total | $44,413 |
Various fair value methodologies were used for the valuation of identifiable intangibles including the 'excess earnings method' used for the valuation of the customer list and 'relief from royalty' method used for the valuation of the trade name. Our fair value was based on the projected financial information and unobservable inputs including revenue growth rate, weighted average cost of capital, royalty rate, and customer attrition rates. Finished goods inventory was valued using the net realizable value approach and approximate the selling price less disposal costs and allowance for a reasonable profit. The goodwill of $12.4 million arising from the acquisition consists largely of intangible assets that do not qualify for separate recognition and were fully assigned to our Retail and Wholesale Products Group. None of the goodwill recognized is expected to be deductible for income tax purposes.
Ultra Pet contributed net sales of $4.8 million and pre-tax income of $0.2 million for the period from May 1, 2024, to July 31, 2024, net of acquisition adjustments including non-cash inventory fair value step up amortization included in cost of goods sold and customer list amortization included in SG&A. The total fair value step up adjustment to inventory was $0.8 million of which $0.4 million was amortized in fiscal year 2024 and the remainder in fiscal year 2025. The following unaudited pro forma summary presents consolidated information of Oil-Dri as if the business combination had occurred on August 1, 2022.
| (unaudited- in thousands) | Pro forma year ended July 31, | |
|---|---|---|
| 2024 | 2023 | |
| Net Sales | $455,139 | $435,093 |
| Pre-Tax Net Income | $52,999 | $35,489 |
These pro forma amounts above have been calculated after applying Oil-Dri’s accounting policies and adjusting the results of Ultra Pet, including the following adjustments:
| (unaudited- in thousands) | Pro forma year ended July 31, | |
|---|---|---|
| 2024 | 2023 | |
| Acquisition related expenses (a) | $1,172 | $— |
| Interest expense (b) | $(1,158) | $(1,323) |
| Customer list amortization (c) | $(850) | $(1,133) |
| Inventory step up adjustment (d) | $449 | $(783) |
(a) Adjustment for acquisition related expenses reflects the reversal of legal and other professional fees and integration costs incurred in fiscal year 2024. These expenses are included in general and administrative expense on Oil-Dri consolidated income statement.
(b) Interest expense adjustments reflect higher interest expense associated with financing the Ultra Pet acquisition assuming financing occurred August 1, 2022.
(c) Customer list amortization adjustment reflects additional amortization assuming amortization began on August 1, 2022.
(d) Inventory step up adjustment reflects the reversal of the amortization recognized in fiscal year 2024 and recognition of the full step up adjustment in fiscal year 2023.
NOTE 3 –OPERATING SEGMENTS
We havetwo reportable operating segments: (1) Retail and Wholesale Products Group and (2) Business to Business Products Group. These operating segments are managed separately, and each segment's major customers have different characteristics. The Retail and Wholesale Products Group customers include mass merchandisers, the farm and fleet channel, drugstore chains, pet specialty retail outlets, dollar stores, retail grocery stores, distributors of industrial cleanup and automotive products, environmental service companies, sports field product users and marketers of consumer products. Given the similar nature of products and customers, sales of our silica gel based crystal litter are included with our cat litter products and reported as part of the Retail and Wholesale products group segment. The Business to Business Products Group customers include processors and refiners of edible oils, renewable diesel, petroleum-based oils and biodiesel fuel; manufacturers of animal feed and agricultural chemicals; and distributors of animal health and nutrition products. Our operating segments are also our reportable segments. The accounting policies of the segments are the same as those described in Note 1 of the Notes to the Consolidated Financial Statements.
Net sales for our principal products by segment are as follows (in thousands):
| Business to Business Products Group · Retail and Wholesale Products Group | ||||||
|---|---|---|---|---|---|---|
| Year Ended July 31, | ||||||
| Product | 2025 | 2024 | 2023 | 2025 | 2024 | 2023 |
| Cat Litter | $— | $— | $— | $255,926 | $241,884 | $226,335 |
| Industrial and Sports | — | — | — | 47,050 | 45,232 | 44,291 |
| Agricultural and Horticultural | 44,338 | 33,558 | 40,275 | — | — | — |
| Bleaching Clay and Fluids Purification | 110,105 | 92,464 | 77,643 | — | — | — |
| Animal Health and Nutrition | 28,153 | 24,449 | 24,477 | — | — | — |
| Net Sales | $182,596 | $150,471 | $142,395 | $302,976 | $287,116 | $270,626 |
Our chief operating decision maker (“CODM”) is our President and CEO. The CODM regularly reviews net sales, gross profit, and operating income by segment to assess profitability and assist in the allocation of resources. Net sales and operating income for each segment are provided below, along with the Significant Segment Expense categories that are regularly provided and used by the CODM when assessing segment profitability and the allocation of resources. The significant amounts within the segment operating expenses include cost of goods sold, compensation and benefits, and advertising. The other operating expenses in the table below is comprised of all other SG&A expenses which include but are not limited to travel, research & development, technical service support, and amortization of intangibles. Our CODM reviews the performance of each segment regularly by analyzing financial results in conjunction with our internal financial forecasts.
The corporate expenses line in the table below represents certain unallocated expenses, including primarily salaries, wages and benefits, purchased services, rent, utilities and depreciation and amortization associated with corporate functions such as information systems, finance, legal, human resources and customer service. Corporate expenses also include the annual incentive plan bonus accrual.
| (in thousands) · Business to Business Products Group · Retail and Wholesale Products Group · Total | ||||
|---|---|---|---|---|
| Net Sales | $182,596 | $302,976 | $485,572 | |
| Cost of Goods Sold | (106,691) | (235,798) | (342,489) | |
| Gross Profit | 75,905 | 67,178 | 143,083 | |
| Compensation and Benefits | (8,748) | (8,366) | (17,114) | |
| Advertising | (1,115) | (6,439) | (7,554) | |
| Other Operating Expenses | (6,246) | (8,236) | (14,482) | |
| Operating Income | 59,796 | 44,137 | 103,933 | |
| Corporate Expenses | (35,713) | |||
| Income from Operations | 68,220 | |||
| Total Other Expense, Net | (2,009) | |||
| Income Before Income Taxes | $66,211 | |||
| Income Tax Expense | $(12,215) | |||
| Net Income | $53,996 | |||
| (in thousands) · Business to Business Products Group · Retail and Wholesale Products Group · Total | ||||
|---|---|---|---|---|
| Net Sales | $150,471 | $287,116 | $437,587 | |
| Cost of Goods Sold | (89,789) | (222,704) | (312,493) | |
| Gross Profit | 60,682 | 64,412 | 125,094 | |
| Compensation and Benefits | (9,109) | (6,645) | (15,754) | |
| Advertising | (891) | (8,148) | (9,039) | |
| Other Operating Expenses | (5,093) | (5,815) | (10,908) | |
| Operating Income | 45,589 | 43,804 | 89,393 | |
| Corporate Expenses | (37,748) | |||
| Income from Operations | 51,645 | |||
| Total Other Expense, Net | (1,994) | |||
| Income Before Income Taxes | $49,651 | |||
| Income Tax Expense | $(10,225) | |||
| Net Income | $39,426 | |||
| (in thousands) · Business to Business Products Group · Retail and Wholesale Products Group · Total | ||||
|---|---|---|---|---|
| Net Sales | $142,395 | $270,626 | $413,021 | |
| Cost of Goods Sold | (89,857) | (219,937) | (309,794) | |
| Gross Profit | 52,538 | 50,689 | 103,227 | |
| Compensation and Benefits | (8,340) | (5,577) | (13,917) | |
| Advertising | (984) | (6,363) | (7,347) | |
| Other Operating Expenses | (5,537) | (4,957) | (10,494) | |
| Operating Income | 37,677 | 33,792 | 71,469 | |
| Corporate Expenses | (30,429) | |||
| Income from Operations | 41,040 | |||
| Total Other Expense, Net | (6,362) | |||
| Income Before Income Taxes | 34,678 | |||
| Income Tax Expense | (5,195) | |||
| Net Income | $29,483 | |||
| Net Loss Attributable to Noncontrolling Interest | $(68) | |||
| Net Income Attributable to Oil-Dri | $29,551 | |||
We do not rely on any operating segment asset allocations and do not consider them meaningful because of the shared nature of our production facilities; however, we have estimated the segment asset allocations below for those assets for which we can reasonably determine. The unallocated asset category is the remainder of our total assets. The asset allocation is estimated and is not a measure used by our chief operating decision maker about allocating resources to the operating segments or in assessing their performance.
| As of July 31, | ||
|---|---|---|
| Assets | ||
| 2025 | 2024 | |
| (in thousands) | ||
| Business to Business Products | $104,857 | $92,300 |
| Retail and Wholesale Products | 200,644 | 200,187 |
| Unallocated assets | 86,176 | 62,118 |
| Total Assets | $391,677 | $354,605 |
The following is a summary by fiscal year of financial information by geographic region (in thousands):
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Sales to unaffiliated customers by: | |||
| Domestic operations | $465,451 | $416,603 | $390,963 |
| Foreign subsidiaries | $20,121 | $20,984 | $22,058 |
| Sales or transfers between geographic areas: | |||
| Domestic operations | $6,534 | $6,102 | $6,436 |
| Foreign subsidiaries | $— | $— | $69 |
| Income (Loss) before income taxes: | |||
| Domestic operations | $66,285 | $48,995 | $33,686 |
| Foreign subsidiaries | $(74) | $656 | $992 |
| Net Income (Loss) attributable to Oil-Dri: | |||
| Domestic operations | $55,192 | $39,729 | $28,494 |
| Foreign subsidiaries | $(1,196) | $(303) | $1,057 |
| Identifiable assets: | |||
| Domestic operations | $382,634 | $345,934 | $271,627 |
| Foreign subsidiaries | $9,043 | $8,671 | $14,608 |
Included within identifiable assets for our foreign subsidiaries is cash held at foreign banks of $4.7 million and $4.5 million as of July 31, 2025, and July 31, 2024, respectively.
Sales to Walmart, our largest customer, are included in our Retail and Wholesale Products Group. The percentage of consolidated net sales and net accounts receivable attributed to Walmart are shown in the table below:
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Net sales for the years ended July 31 | 19% | 20% | 19% |
| Net accounts receivable as of July 31 | 23% | 23% | 26% |
There are no other customers with sales equal to or greater than 10% of our total sales.
NOTE 4 –DEBT
The composition of long-term debt is as follows as of July 31 (in thousands):
| 2025 | 2024 | |
|---|---|---|
| Amended and Restated Note Purchase and Private Shelf Agreement. Annual principal installments on May 15: $1,000 in each fiscal year 2021 through 2030. Interest is payable semi-annually at an annual rate of 3.95% [Series B] | $5,000 | $6,000 |
| Amended and Restated Note Purchase and Private Shelf Agreement. Annual principal installments on Dec 15: $5,000 in each fiscal year 2028 through 2032. Interest is payable semi-annually at an annual rate of 3.25% [Series C] | 25,000 | 25,000 |
| Amended and Restated Note Purchase and Private Shelf Agreement. Annual principal installments on April 30: $5,000 in each fiscal year 2032 through 2033. Interest is payable semi-annually at an annual rate of 6.47% [Series D] | 10,000 | 10,000 |
| Seventh Amendment to Credit Agreement. Full principal amount is due on May 1, 2026 | — | 10,000 |
| Less current maturities of notes payable | (1,000) | (1,000) |
| Less unamortized debt issuance costs | (183) | (226) |
| Long-term debt | $38,817 | $49,774 |
We are party to the Note Agreement with Prudential and certain existing noteholders and purchasers affiliated with Prudential named therein. Pursuant to the Note Agreement, (i) on May 15, 2020, we issued $10 million in aggregate principal amount of our 3.95% Series B Senior Notes due May 15, 2030 (the "Series B Senior Notes"), of which $5 million aggregate principal amount remained outstanding as of July 31, 2025, (ii) on December 16, 2021, we issued an additional $25 million in aggregate principal amount of our 3.25% Series C Senior Notes due December 16, 2031 (the "Series C Senior Notes"), all of which remained outstanding as of July 31, 2025, and (iii) on April 30, 2024 we issued $10 million in aggregate principal amount of our 6.47% Series D Senior Notes due April 30, 2033 (the "Series D Senior Notes"), all of which remained outstanding as of July 31, 2025. The Note Agreement also provides us with the ability to request, from time to time until September 30, 2029, that Prudential affiliate(s) purchase, at Prudential’s discretion and on an uncommitted basis, additional senior unsecured notes of Oil-Dri (the “Shelf Notes,” and collectively with the Series B Senior Notes, Series C Senior Notes, and Series D Senior Notes, the “Notes”) in an aggregate principal amount of up to $75 million minus the aggregate principal amount of Notes then outstanding and Shelf Notes that have been accepted for purchase. Interest payable on any Shelf Note agreed to be purchased under the Note Agreement will be at a rate determined by Prudential and will mature no more than fifteen years after the date of original issue of such Shelf Note.
The following is a schedule by fiscal year of future principal maturities of notes payable as of July 31, 2025 (in thousands):
| 2026 | $1,000 |
| 2027 | 1,000 |
| 2028 | 6,000 |
| 2029 | 6,000 |
| 2030 | 6,000 |
We are party to the Credit Agreement with BMO Harris, which provides for a $75 million unsecured revolving credit facility, including a maximum of $20 million for letters of credit.
The Credit Agreement contains restrictive covenants that, among other things and under various conditions, limit our ability to incur additional indebtedness or to dispose of assets. These restrictive covenants include certain financial covenants such as a covenant to maintain a maximum debt to earnings ratio and to maintain a certain fixed charge coverage ratio. On September 30, 2024, the Company entered into the Eighth Amendment to Credit Agreement (the “Eighth Amendment”). The Eighth Amendment amends the Credit Agreement to, among other things: (i) increase the amount the Company may borrow from BMO Harris from time to time pursuant to its revolving line of credit from up to $45 million to up to $75 million; (ii) increase the aggregate maximum amount of letters of credit from up to $10 million to up to $20 million; (iii) add an accordion provision to allow the Company to increase the revolving line of credit by up to an additional $50 million, subject to the terms and conditions set forth in the Eighth Amendment; (iv) extend the termination date to September 30, 2029; and (v) increase certain restrictive covenant thresholds, including but not limited to, an increase to the permitted acquisitions threshold in the restricted covenants from a cumulative total of $45 million to $100 million.
As of July 31, 2025, and July 31, 2024, we were in compliance with the restrictive covenants under the Credit Agreement. During fiscal year 2025, there wereno new borrowings; however, we elected to pay down $10 million of our borrowings under the Credit Agreement. As of July 31, 2025, we donot have any outstanding borrowings under the Credit Agreement. We had $3.0 million of letters of credit outstanding under the Credit Agreement as of July 31, 2025, and $2.9 million as of July 31, 2024.
The Credit Agreement states that we may select a variable interest rate based on either the Bank of Montreal ("BMO") prime rate or an adjusted SOFR-based rate, plus a margin that varies depending on our debt to earnings ratio, or a fixed rate as agreed between us and BMO. As of July 31, 2025, the variable rates would have been 7.50% for the BMO prime-based rate or 5.55% for the adjusted SOFR-based rate.
NOTE 5 –FINANCIAL INSTRUMENTS
Fair Value
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The inputs used to measure fair value are prioritized into one of three categories based on the lowest level of input that is significant to the fair value measurement. Categories in the hierarchy are as follows:
Level 1: Quoted market prices in active markets for identical assets or liabilities.
Level 2: Observable market-based inputs for similar assets or liabilities or valuation models whose inputs are observable, directly or indirectly.
Level 3: Unobservable inputs.
Cash equivalents are classified as Level 1 of the fair value hierarchy because they are valued using quoted market prices in active markets. These cash instruments are primarily money market funds and are included in cash and cash equivalents on the Consolidated Balance Sheets. We had $35.3 million cash equivalents as of July 31, 2025, and had $3.0 million cash equivalents as of July 31, 2024.
Balances of accounts receivable, short-term investments and accounts payable approximated their fair values on July 31, 2025, and July 31, 2024, due to the short maturity and nature of those balances.
Debt is reported at outstanding face value, less unamortized debt issuance costs. The estimated fair value of debt, including current maturities, was approximately $40.3 million as of July 31, 2025, and $51.1 million as of July 31, 2024. The fair value was estimated using the exit price notion of fair value and is classified as Level 2. See Note 4 of the Notes to the Consolidated Financial Statements for further information about such debt.
We apply fair value techniques on at least an annual basis associated with: (1) valuing potential impairment loss related to goodwill, trademarks and other indefinite-lived intangible assets and (2) valuing potential impairment loss related to long-lived assets. See Note 1 of the Notes to Consolidated Financial Statements for further information about goodwill and other intangible assets.
Concentration of Credit Risk
Financial instruments which potentially subject us to concentrations of credit risk consist principally of cash and accounts receivable. Our cash is held in banks which are covered by the Federal Deposit Insurance Corporation; however, our cash balances are in excess of the maximum amount that is insured. Concentrations of credit risk with respect to accounts receivable are subject to the financial condition of certain major customers, principally the customer referred to in Note 3 of the Notes to the Consolidated Financial Statements. We generally do not require collateral to secure customer receivables.
NOTE 6 –INCOME TAXES
The provision for income tax expense by fiscal year consists of the following (in thousands):
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Current | |||
| Federal | $8,790 | $6,059 | $7,503 |
| State | 2,959 | 2,243 | 2,119 |
| Foreign | 226 | 226 | 4 |
| Current Income Tax Total | 11,975 | 8,528 | 9,626 |
| Deferred | |||
| Federal | 433 | 934 | (3,864) |
| State | (233) | 778 | (567) |
| Foreign | 40 | (15) | — |
| Deferred Income Tax Total | 240 | 1,697 | (4,431) |
| Total Income Tax Expense | $12,215 | $10,225 | $5,195 |
Principal reasons for variations between the statutory federal rate and the effective rates by fiscal year were as follows:
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| U.S. federal income tax rate | 21.0% | 21.0% | 21.0% |
| Depletion deductions allowed for mining | (4.5) | (5.3) | (7.7) |
| State income tax expense, net of federal tax expense | 3.6 | 3.5 | 2.9 |
| Nondeductible officer compensation | 1.3 | 2.2 | 1.5 |
| Stock Based Compensation | (1.0) | (2.1) | — |
| U.S. Tax Impacts of Foreign Branch | 0.4 | 1.3 | (0.2) |
| Tax credits | (0.4) | (0.2) | (0.3) |
| Valuation allowance - foreign | 0.5 | 0.4 | (0.2) |
| Statutory rate change of foreign subsidiaries | (0.1) | 0.3 | — |
| Prior year income taxes | (1.7) | (0.3) | (1.3) |
| Foreign tax differential | (0.1) | 0.1 | (0.6) |
| Other | (0.6) | (0.3) | (0.1) |
| Effective income tax rate | 18.4% | 20.6% | 15.0% |
The combination of tax credits claimed in fiscal year 2025 contributed to a reduction in the effective tax rate when compared to fiscal year 2024.
The Consolidated Balance Sheets included the following tax effects of cumulative temporary differences as of July 31 (in thousands):
`
| 2025 | 2024 | |||
|---|---|---|---|---|
| Assets | Liabilities | Assets | Liabilities | |
| Amortization | $— | $5,863 | $— | $6,307 |
| Depreciation | — | 6,237 | — | 5,692 |
| Lease liabilities | 3,961 | — | 5,105 | — |
| Lease right of use assets | — | 3,670 | — | 4,778 |
| Accrued expenses | 4,494 | — | 4,347 | — |
| Federal & State NOL carryforward | 2,470 | — | 2,975 | — |
| Stock-based compensation | 2,214 | — | 1,894 | — |
| Foreign NOL carryforward | 2,197 | — | 1,889 | — |
| Deferred compensation | 1,931 | — | 1,603 | — |
| Capitalized R&D | 1,029 | — | 783 | — |
| Reclamation | 785 | — | 712 | — |
| Other assets | 555 | — | 693 | — |
| Postretirement benefits | 422 | — | 454 | — |
| Inventories | 185 | — | 435 | — |
| Depletion | — | 121 | — | 141 |
| Allowance for credit losses | 213 | — | 85 | — |
| Other liabilities | — | 428 | — | 33 |
| Other liabilities - foreign | — | — | 8 | 17 |
| Valuation allowance | (2,846) | — | (2,470) | — |
| Total deferred taxes | $17,610 | $16,319 | $18,513 | $16,968 |
Deferred tax assets and liabilities related to leases decrease as leases expire.
We recorded a valuation allowance of $2.8 million and $2.5 million as of July 31, 2025 and July 31, 2024, respectively, for the amount of the deferred tax benefit related to our foreign net operating loss carryforwards and certain state net operating loss carryforwards since we believe it is unlikely we will realize the benefit of these tax attributes in the future. As of July 31, 2025, we have total net operating loss carryforwards from state jurisdictions of approximately $13.0 million. The carryforward expiration dates vary by state.
With the exception of our foreign subsidiary in Canada, none of our foreign subsidiaries have generated any untaxed foreign income, therefore we have not provided for any related income taxes for these subsidiaries.
We hadno liabilities for unrecognized tax benefits based on tax positions related to the current and prior fiscal years as of July 31, 2025 and 2024; correspondingly, no related interest and penalties were recognized as income tax expense and there wereno accruals for such items in either of these fiscal years.
We are subject to U.S. federal income tax as well as income tax in multiple state and foreign jurisdictions. We were audited by the Internal Revenue Service ("IRS") for fiscal year 2020 with no adjustments upon closure of the audit. The federal tax returns for fiscal years 2021-2024 remain open for examination. Foreign and U.S. state jurisdictions have statutes of limitations generally ranging from 3 to 5 years. The state impact of any federal income tax changes remains subject to examination by various states for a period of up to one year after formal notification to the states. There are a limited number of open state and local income tax audits in which no material issues have been preliminarily identified. There are no material open or unsettled foreign income tax audits. We believe our accrual for tax liabilities is adequate for all open audit years.
NOTE 7 – ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
The following table summarizes the changes in accumulated other comprehensive income by component (in thousands):
| Postretirement Health Benefits | Cumulative Translation Adjustment | Total Accumulated Other Comprehensive (Loss) Income | |
|---|---|---|---|
| Balance as of July 31, 2023 | $1,012 | $(264) | $748 |
| Other comprehensive income (loss) before reclassifications, net of tax | 150 | (43) | 107 |
| Amounts reclassified from accumulated other comprehensive income, net of tax | (86) | — | (86) |
| Net current-period other comprehensive income (loss), net of tax | 64 | (43) | 21 |
| Balance as of July 31, 2024 | $1,076 | $(307) | $769 |
| Other comprehensive income (loss) before reclassifications, net of tax | 224 | 71 | 295 |
| Amounts reclassified from accumulated other comprehensive income, net of tax | (95) | — | (95) |
| Net current-period other comprehensive income (loss), net of tax | 129 | 71 | 200 |
| Balance as of July 31, 2025 | $1,205 | $(236) | $969 |
NOTE 8 –STOCK-BASED COMPENSATION
The 2006 Plan permits the grant of stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards and other stock-based and cash-based awards. Our employees and outside directors are eligible to receive grants under the 2006 Plan. The total number of shares of stock subject to grants under the 2006 Plan may not exceed 3,439,000. As of July 31, 2025, there were 1,074,120 shares of Common Stock or Class B Stock available for future grants under this plan.
RESTRICTED STOCK
All non-vested restricted stock as of July 31, 2025, was issued under the 2006 Plan with vesting periods generally fromone tofive years. The fair value of restricted stock was determined by the closing market price of our Common Stock on the date of grant multiplied by the number of shares granted. Fair value of shares vested in fiscal years 2025, 2024, and 2023 is $6.6 million, $9.8 million, and $2.2 million, respectively as of their vesting dates.
A summary of restricted stock transactions under the plans is shown below.
| Number ofShares(in thousands) | WeightedAverageGrant DateFair Value | WeightedAverageRemainingContractualTerm(Years) | UnamortizedExpense(in thousands) | |
|---|---|---|---|---|
| Non-vested restricted stock outstanding at July 31, 2022 | 762 | $16.82 | 3.0 | $7,064 |
| Granted | 127 | $14.94 | ||
| Vested | (145) | $17.53 | ||
| Forfeited | (48) | $14.61 | ||
| Non-vested restricted stock outstanding at July 31, 2023 | 696 | $16.48 | 2.3 | $5,129 |
| Granted | 429 | $31.53 | ||
| Vested | (307) | $15.68 | ||
| Forfeited | (23) | $19.54 | ||
| Non-vested restricted stock outstanding at July 31, 2024 | 795 | $24.82 | 3.4 | $13,360 |
| Granted | 143 | $38.29 | ||
| Vested | (183) | $20.17 | ||
| Forfeited | (27) | $27.76 | ||
| Non-vested restricted stock outstanding at July 31, 2025 | 728 | $28.52 | 3.0 | $12,713 |
Stock-based compensation for restricted stock of $4.1 million, $3.7 million, and $2.4 million, net of related tax effect, was recognized in fiscal years 2025, 2024, and 2023, respectively. The total restricted stock compensation related tax benefit was $1.3 million, $1.2 million, and $0.8 million in fiscal years 2025, 2024, 2023, respectively.
NOTE 9 –DEFERRED COMPENSATION
Oil-Dri's deferred compensation plans permit directors and certain management employees to defer portions of their compensation and to earn interest on the deferred amounts. Participants deferred $0.6 million, $0.3 million, and $0.6 million into these plans in fiscal years 2025, 2024, and 2023, respectively. We recorded interest expense of $0.3 million, $0.2 million, and $0.2 million related to these plans in fiscal years 2025, 2024, and 2023, respectively. Payments to participants were $0.2 million, $0.4 million, and $0.9 million in fiscal years 2025, 2024, and 2023, respectively, and the total liability recorded for deferred compensation was $5.6 million, $5.0 million, and $4.6 million as of July 31, 2025, 2024, and 2023, respectively.
The Oil-Dri Corporation of America Annual Incentive Plan provides certain executives with the opportunity to receive a deferred executive bonus award if certain financial goals are met. Deferred executive bonus awards of $1.4 million, $1.9 million, and $1.4 million were awarded for fiscal years 2025, 2024, and 2023, respectively as financial targets under the provisions of the plan were achieved. These awards will vest and accrue interest over a 3-year period.
Our deferred compensation plans are unfunded. We fund these benefits when payments are made, and the timing and amount of the payments are determined according to the plans' provisions and, for certain plans, according to individual employee agreements.
NOTE 10 -ACCRUED EXPENSES
Accrued expenses are as follows (in thousands):
| July 31,2025 | July 31,2024 | |
|---|---|---|
| Salaries, Wages, Commissions and Employee Benefits | $20,532 | $20,711 |
| Payables | 13,036 | 11,586 |
| Trade promotions and advertising | 3,105 | 2,743 |
| Freight | 2,700 | 2,928 |
| Taxes | 2,249 | 1,736 |
| Georgia Landfill Modification Reserve | 819 | 1,208 |
| Other | 2,423 | 3,104 |
| $44,864 | $44,016 |
NOTE 11 –OTHER CONTINGENCIES
We are party to various legal actions that arise from time to time that are ordinary in nature and incidental to the operation of our business, including ongoing litigation. While it is not possible at this time to determine with certainty the ultimate outcome of these or other lawsuits, we believe that none of the pending proceedings will have a material adverse effect on our business, financial condition, results of operations or cash flows.
In fiscal year 2023, we recorded a reserve of $2.5 million for anticipated modification costs that we expected to incur to address capacity issues at our sole landfill located in Ochlocknee, Georgia. Reserves are recorded when it is probable that a liability has been incurred, and the amount of the liability can be reasonably estimated. The amount of the reserve represented management’s best estimate of the costs for the modification with respect to this matter, at the time. Work began on the modifications during fiscal year 2024. We increased the total estimated cost by $0.6 million and $0.7 million in fiscal years 2024 and 2025, respectively, resulting in a total $3.8 million expense related to this matter. The modification work is expected to be completed during fiscal year 2026. Inherent uncertainties exist in these estimates primarily due to unknown conditions, changing government regulations and legal standards, and emerging technologies for handling site modification. Consequently, it is reasonably possible that modification costs in excess of amounts accrued could have a material impact on the Company’s results of operations, financial condition and cash flows.
NOTE 12 –LEASES
We have operating leases primarily for real estate properties, including corporate headquarters, customer service and sales offices, manufacturing and packaging facilities, warehouses, and research and development facilities, as well as for rail tracks, railcars and office equipment. Our leases for a shared warehouse, office facility, and railcars have options to extend which we are reasonably certain we will exercise and, accordingly, have been considered in the lease term used to recognize our ROU assets and lease liabilities. To determine the present value of the lease liability, we use an incremental borrowing rate, which is defined as the rate of interest that the Company would have to pay to borrow (on a collateralized basis over a similar term) an amount equal to the lease payments in similar economic environments. As provided in ASC 842, we have elected not to apply these measurement and recognition requirements to short-term leases (i.e., leases with a term of 12 months or less). Short-term leases will not be recorded as ROU assets or lease liabilities on our consolidated balance sheet, and the related lease payments will be recognized in net earnings on a straight-line basis over the lease term.
We have no material finance leases, and variable costs for operating leases are immaterial. Operating lease costs are included in Cost of Goods Sold or SG&A expenses based on the nature of the lease. The following table summarizes total lease costs for our operating leases (in thousands):
| For the Twelve Months Ended July 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Operating lease cost | $5,320 | $3,791 | $2,640 |
Supplemental cash flow information related to leases was as follows (in thousands):
| For the Twelve Months Ended July 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Other Information | |||
| Cash paid for amounts included in the measurement of lease liabilities: | $4,515 | $3,112 | $2,229 |
| Right-of-use assets obtained in exchange for new operating lease liabilities | 1 | 11,471 | 983 |
Operating lease ROU assets and operating lease liabilities are separately presented on the Consolidated Balance Sheets. Other supplemental balance sheet information related to leases was as follows:
| For the Twelve Months Ended July 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Weighted-average remaining lease term - operating leases | 4.8 years | 5.4 years | 7.7 years |
| Weighted-average discount rate - operating leases | 5.12% | 5.10% | 4.03% |
The following table summarizes scheduled minimum future lease payments due within twelve months for operating leases with terms longer than one year for which cash flows are fixed and determinable as of July 31, 2025 (in thousands):
| 2026 | $4,740 |
| 2027 | 3,758 |
| 2028 | 2,949 |
| 2029 | 2,356 |
| 2030 | 1,130 |
| Thereafter | 2,350 |
| Total | 17,283 |
| Less: imputed interest | (1,916) |
| Net lease obligation | $15,367 |
NOTE 13 –RELATED PARTIES
One member of our Board is currently the President and Chief Executive Officer of a vendor of ours. Total payments to this vendor for fees and cost reimbursements were $1.6 million, $2.0 million, and $0.2 million for fiscal years 2025, 2024, and 2023, respectively. There wereno outstanding fees due to that vendor as of July 31, 2025. There were $0.1 million outstanding amounts due to that vendor as of July 31, 2024.
One member of our Board retired from the role of President and Chief Executive Officer of a customer of ours on September 28, 2019, and was party to a post-employment consulting agreement with the customer until September 30, 2025. Total sales to that customer, including sales to subsidiaries of that customer, were $0.4 million for fiscal year 2025 and $0.2 million for both fiscal year 2024 and 2023. There wereno outstanding amounts due from that customer as of July 31, 2025, or 2024.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.